Clemens Huettenbrink

Paracelsus Medizinische Privatuniversität

Papers

1

Total Citations

9

H-Index

1

About

Clemens Huettenbrink is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes and patient-reported experiences in prostate cancer care. His primary research areas include robotic-assisted surgery, patient regret, and functional recovery following radical prostatectomy. Dr. Huettenbrink’s major contribution lies in pioneering the use of patient regret as a critical endpoint for treatment evaluation, moving beyond traditional clinical metrics to capture the patient’s perspective. His landmark multicenter cross-sectional IMPROVE study, which has garnered significant attention, demonstrated that patients who underwent robot-assisted radical prostatectomy (RARP) reported significantly less regret about their treatment choice compared to those who had open surgery. This finding has profound implications for shared decision-making and surgical counseling. With a growing citation impact, his work is shaping modern urologic oncology by emphasizing the importance of patient-centered outcomes. Dr. Huettenbrink’s research bridges the gap between surgical innovation and quality of life, making him a key voice in the evolution of prostate cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Patients Regret Their Choice of Therapy Significantly Less Frequently after Robot-Assisted Radical Prostatectomy as Opposed to Open Radical Prostatectomy: Patient-Reported Results of the Multicenter Cross-Sectional IMPROVE Study
9 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 31
🏛 Institutions: Paracelsus Medizinische Privatuniversität

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago